Skip to content

    DCW

    DCW
    Chemicals·13 May 2025
    Management Summary

    DCW delivered a resilient performance in FY25, with revenue growing 7% and PAT doubling, largely driven by strong growth in its Specialty Chemicals segment and significant deleveraging. Despite facing headwinds in its Basic Chemicals segment due to global demand softness and import pressures, the company is executing strategic capacity expansions and operational improvements. Management remains optimistic about future growth, particularly from specialty chemicals and anticipated market normalization.

    Highlights

    5
    • Full-year FY25 Revenue grew 7% to ₹2,000 crores, demonstrating resilience in a volatile market.

    • Full-year FY25 EBITDA increased 12% to ₹217 crores, driven by strong specialty chemicals performance.

    • Profit After Tax (PAT) for FY25 doubled to ₹30 crores, reflecting improved operational efficiency and reduced finance costs.

    • Net debt-to-EBITDA ratio significantly improved to 0.97x (below 1x) in FY25 from 1.4x in FY24, marking a critical deleveraging milestone.

    • Specialty Chemicals segment showed robust growth, with revenue up 43% to ₹526 crores and EBITDA up 41% to ₹189 crores in FY25.

    Concerns

    4
    • Q4 FY25 Revenue declined 13% YoY to ₹538 crores, primarily due to weak export demand and lower realizations in Synthetic Rutile and Soda Ash.

    • Basic Chemicals segment EBITDA dropped 59% in FY25 to ₹19 crores, impacted by severe pricing pressures from low-cost imports and a 7% dip in Soda Ash prices.

    • Persistent pricing pressure from Chinese imports and delayed anti-dumping duty on PVC continue to challenge domestic manufacturers.

    • Muted global demand, especially in Western economies and China, intensified challenges in the chemical industry.

    What Changed2

    vs Q1 FY26

    Guidance items2 → 5 (+3)Risks discussed5 → 4 (-1)

    Key financials

    Single quarter

    06 metrics
    1. 01Revenue₹538 Cr-13%YoY
    2. 02EBITDA₹62 Cr-10.5%YoY
    3. 03PAT₹30 Cr+100%YoY
    4. 04EBITDA Margin11%
    5. 05ROCE8%

    Segment breakdown

    • Specialty Chemicals₹526 Cr26.4%
    • Basic Chemicals₹1,463 Cr73.6%
    Donut· Share of Revenue (FY25)

    Capital allocation

    3
    high confidence
    CategoryHeadline
    Capex

    Capex disclosed

    Debt

    1.0x EBITDA

    Liquidity

    Cash ₹215 crores

    Cash and cash equivalents increased by INR 46 crores from March '24.

    Guidance & targets

    5
    CategoryTargetPriority
    Profitability
    EBITDA
    ₹400 crores
    Medium
    Capacity
    C-PVC Capacity Commissioning (20,000 tons)
    Commissioned
    High
    Capacity
    C-PVC Capacity Commissioning (remaining 10,000 tons)
    Commissioned
    High
    Volume
    Soda Ash Production
    95,000 tons
    High
    Export
    Synthetic Rutile Annual Production Contracted
    70%
    High

    C-PVC Capacity Commissioning (20,000 tons)

    By September 2025 (H2 FY26)
    CurrentUnder construction, progressing ahead of schedule
    TargetCommissioned

    Why it matters

    This is a key driver for specialty chemicals volume and earnings growth, expected to provide a meaningful step-up in H2 FY26.

    Our 30,000 tons C-PVC capacity expansion at our Sahupuram site is progressing ahead of schedule. We expect to commission the first 20,000 tons of this incremental capacity before the timeline of September 2025, which will give us a meaningful step-up in our specialty volumes for the second half of FY '26.

    How to verify

    guidance_and_targets[metric='C-PVC Capacity Commissioning (20,000 tons)']

    Risks & concerns

    4
    RiskSeverity

    China Overcapacity and Dumping

    Persistent pricing pressure caused by surge in low-cost imports from China, especially in PVC and Soda Ash, impacting domestic margins.Management acknowledged

    high

    Geopolitical Shifts and Trade Tensions

    Potential U.S. trade tariffs and shifting alliances causing disruptions in traditional trade flows and raising uncertainty, though management believes they have an edge over China for US exports.Management acknowledged

    medium

    Delay in Anti-Dumping Duty on PVC

    The much anticipated anti-dumping duty on PVC has been delayed, impacting the competitive landscape for domestic manufacturers.Management acknowledged

    medium

    Muted Global Demand

    Muted global demand, especially in Western economies and China, contributed to challenges in the chemical industry, though India remains a growing market.Management acknowledged

    medium

    Q&A highlights

    8

    “You send your questions via mail. The basic idea was basically to now present the numbers as basic chemicals and specialty chemicals, as opposed to giving information at a product level.”

    Management declined to provide detailed product-level financial breakdowns, indicating a shift in reporting strategy that may limit investor visibility into specific product performance.

    asked by Pujan Shah

    2 min read6 chapters

    Detailed Narrative

    01

    Q4 FY25 and Full Year FY25 Performance Overview

    DCW reported a Q4 FY25 revenue of ₹538 crores, a 13% decline from Q4 FY24, but a 13% sequential increase. For the full year FY25, revenue reached ₹2,000 crores, up 7% from ₹1,872 crores in FY24. EBITDA for Q4 FY25 stood at ₹62 crores, a 10.5% dip YoY, while full-year FY25 EBITDA grew 12% to ₹217 crores. The company's PAT for FY25 doubled to ₹30 crores, driven by strong specialty chemicals performance and reduced finance costs.

    02

    Strategic Shift Towards Specialty Chemicals

    The company is actively pursuing a strategic shift towards higher-margin specialty chemicals. In FY25, the Specialty Chemicals segment's revenue grew 43% to ₹526 crores from ₹368 crores in FY24, with its EBITDA increasing 41% to ₹189 crores. Management highlighted that approximately 90% of the company's profit in the last fiscal year came from the specialty segment, underscoring its growing importance for margin resilience and stability.

    03

    Challenges in Basic Chemicals Segment

    The Basic Chemicals segment faced significant headwinds, with its FY25 revenue declining 2% to ₹1,463 crores and EBITDA dropping 59% to ₹19 crores. This decline was primarily attributed to severe pricing pressures on Synthetic Rutile exports to China and a 7% dip in Soda Ash prices. The influx of cheaper imports, particularly from China, due to lower ocean freights and trade tensions, intensified competitive pressures on domestic pricing.

    04

    Capacity Expansion and Operational Improvements

    DCW is on track with its 30,000 tons C-PVC capacity expansion at Sahupuram, with the first 20,000 tons expected to be commissioned by September 2025 and the remaining 10,000 tons by March. An alternate energy project has been commissioned and is being scaled up to optimize energy costs and reduce carbon footprint. The Soda Ash plant, which operated at 80% capacity in FY25 due to mechanical issues, is expected to achieve 95,000 tons production in FY26, a 20% growth.

    05

    Financial Strengthening and Deleveraging Efforts

    The company achieved a significant deleveraging milestone, bringing its net debt-to-EBITDA ratio to 0.97x in FY25, down from 1.4x in FY24. Finance costs reduced by 8.5% to ₹67 crores in FY25. The outstanding term loan decreased by ₹44 crores to ₹366 crores, despite a new borrowing of ₹80 crores for C-PVC capex. Cash and cash equivalents also increased by ₹46 crores to ₹215 crores, indicating a healthy liquidity position.

    06

    Market Outlook and Policy Expectations

    Management acknowledged the persistent volatility in the global chemical industry and muted demand in Western economies. They expressed hope for government intervention, specifically the implementation of anti-dumping duties on PVC, to ensure a level playing field for domestic manufacturers. Despite near-term market fluctuations, the company remains confident in India's structural growth and its strategy to focus on value-added specialty chemicals with higher margins and customer stickiness.

    This is an AI-generated summary of a publicly available earnings call transcript. It is for informational purposes only and does not constitute investment advice, a recommendation, or an endorsement. inve.money is not a SEBI-registered investment advisor. Please consult a qualified financial advisor before making any investment decisions.